文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

加拿大三大城市男男性行为者HPV疫苗接种率及障碍因素

Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019.
PubMed 文献 · Vaccine · 2021-05-29

研究基于2017-2019年加拿大三城社区招募的男男性行为者队列,描述HPV疫苗接种率并分析启动接种的相关因素。

要点

  • ≤26岁免费资格者中仅26-35%启动、14-21%完成HPV疫苗。
  • ≥27岁者启动率7-26%,完成率2-9%,高费用可能部分解释低接种。
  • 近期性病/HIV检测或甲肝/乙肝疫苗接种者更可能启动HPV疫苗。

核心结论

  • ≥27岁者接种率更低,高疫苗费用可能部分解释。
  • 寻求性健康服务者更可能启动接种,捆绑服务或可提高接种率。

研究设计与样本

  • Engage队列研究,2017-2019年从加拿大三城经受访者驱动抽样招募≥16岁男男性行为者。
  • 基线问卷收集数据,按免费疫苗资格(≤26岁合格,≥27岁不合格)分析。
  • 采用Poisson回归探索启动接种相关因素,所有分析经RDS-II Volz-Heckathorn估计量加权。

主要发现

  • ≤26岁者启动率26-35%、完成率14-21%;≥27岁者启动率7-26%、完成率2-9%。
  • 启动接种与过去6个月性病/HIV检测或就诊HIV专科相关(≤26岁PR=2.15,95%CI 1.06-4.36;≥27岁PR=2.73,95%CI 1.14-6.51)。
  • 启动接种与既往甲肝或乙肝疫苗接种相关(≤26岁PR=2.88,95%CI 1.64-5.05;≥27岁PR=2.03,95%CI 1.07-3.86)。
  • ≥27岁者中,启动接种与使用PrEP、居住于温哥华或多伦多正相关,与拉丁美洲裔身份及年龄增长负相关。
  • ≥27岁有私人保险者启动接种可能性是无保险者的两倍。

临床怎么用

  • 将HPV疫苗接种与性健康服务(如性病/HIV检测、PrEP)捆绑提供,可能提高男男性行为者接种率。
  • 对≥27岁无保险者需关注疫苗费用障碍,探索支付支持策略。

局限性

  • 原文摘要未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In 2015/2016, Canada's largest provinces implemented publicly-funded human papillomavirus (HPV) vaccination programs for gay, bisexual, and other men who have sex with men (GBM) ≤ 26 years old. We sought to describe HPV vaccine uptake among GBM and determine barriers and facilitators to vaccine initiation with a focus on healthcare access and utilization. METHODS: Engage is a cohort study among GBM aged 16 + years in three Canadian cities recruited from 2017 to 2019 via respondent driven sampling (RDS). Men completed a comprehensive questionnaire at baseline. By publicly-funded vaccine eligibility (≤26 years old = eligible for vaccination, ≥27 years old = ineligible), we described HPV vaccine uptake (initiation = 1 + dose, completion = 3 doses) and explored factors associated with vaccine initiation using Poisson regression. All analyses were weighted with the RDS-II Volz-Heckathorn estimator. RESULTS: Across the three cities, 26-35% and 14-21% of men ≤ 26 years and 7-26% and 2-9% of men ≥ 27 years initiated and completed HPV vaccination, respectively. Vaccine initiation was significantly associated with STI/HIV testing or visiting a HIV care specialist in the past six months (≤26: prevalence ratio[PR] = 2.15, 95% confidence interval[CI] 1.06-4.36; ≥27: PR = 2.73, 95%CI 1.14-6.51) and past hepatitis A or B vaccination (≤26: PR = 2.88, 95%CI 1.64-5.05; ≥27: PR = 2.03, 95%CI 1.07-3.86). Among men ≥ 27 years old, vaccine initiation was also positively associated with accessing PrEP, living in Vancouver or Toronto, but negatively associated with identifying as Latin American and increasing age. Vaccine initiation was twice as likely among men ≥ 27 years with private insurance versus no insurance. CONCLUSIONS: Sixty-five to 74% of men eligible for publicly-funded vaccine across the three cities remained unvaccinated against HPV by 2019. High vaccine cost may partly explain even lower uptake among men ≥ 27 years old. Men seeking sexual health care were more likely to initiate vaccination; bundling vaccination with these services may help improve HPV vaccine uptake.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Grewal R, Deeks SL, Hart TA, et al. Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019. Vaccine. 2021. PMID: 34074547. doi:10.1016/j.vaccine.2021.05.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。